Commentary Open Access
Systemic lidocaine in bariatric surgery: advances and perspectives in anesthesiology and multimodal pain management – a commentary
Timur Yurttas1,*, Sebastian Jud1, Miodrag Filipovic2
- 1Department of Anaesthesiology, Rescue– and Pain Medicine, Cantonal Hospital St. Gallen, St. Gallen, HOCH Health Ostschweiz, Switzerland
- 2Department of Perioperative Intensive Care Medicine, Cantonal Hospital St. Gallen, St. Gallen, HOCH Health Ostschweiz, Switzerland
Corresponding Author
Timur Yurttas, Timur.Yurttas@h-och.ch
Received Date: February 05, 2026
Accepted Date: February 26, 2026
Yurttas T, Jud S, Filipovic M. Systemic lidocaine in bariatric surgery: advances and perspectives in anesthesiology and multimodal pain management – a commentary. J Clin Anesth Intensive Care. 2026;6(1):1-5.
Copyright: © 2026 Yurttas T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Interaction effects of FTO polymorphisms on post-surgery weight, and post-BMI after bariatric surgery
Obesity is associated with increased morbidity and mortality and is a risk factor for cardiovascular disease. Therefore, preventing and treating obesity has become a major public health goal. Bariatric surgery is considered the intervention most effective for patients with severe obesity (BMI ≥40 kg/m2 or ≥35 kg/m2) with comorbidities and to maintain weight loss and glycemic control in the long-term. In addition, improvement or long-term remission of comorbidities such as T2D, hypertension, and dyslipidemia after bariatric surgery has been reported.
Systemic lidocaine in bariatric surgery: advances and perspectives in anesthesiology and multimodal pain management – a commentary
Patients undergoing bariatric surgery have increased vulnerability to opioid-related adverse events, making multimodal and opioid-sparing strategies a clinical priority. Evidence for perioperative systemic lidocaine in bariatric surgery is controverse; pooled benefits in meta-analyses coexist with neutral findings in some contemporary randomized trials.